Zelis, headquartered in USA, remains privately held in the healthtech financial services space. Its shares do not trade on a public exchange.
Zelis has no published valuation.
No funding round for Zelis has been disclosed yet.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Zelis.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Zelis availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Zelis included.
The routes section explains what is realistically available for a company at this stage.
No. Zelis is a private company; its shares do not trade on a public exchange.
The closest healthtech financial services peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
